Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACR GlobeNewswire (press release) Metastatic ccRCC is well known for its aggressive nature and poor prognosis, with approximately 20-40% of patients relapsing within 5 years of nephrectomy. Also, metastatic ccRCC is largely refractory to conventional treatments with a five-year ... |
